Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Compare 6-month and 12-month emergency funds to determine the best target for your finances, weighing liquidity, security, and timelines.
24,819 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
As MiCA’s July 1 deadline approaches, EU platforms must be MiCA-compliant, while the UK maintains its own FCA framewo...
Beazer Homes stock zooming higher this week has investors buzzing about a potential takeover. This article breaks dow...
On Tuesday morning, Lockheed Martin stock dropped sharply before trimming losses. This deep dive explains the mix of ...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
Waymo’s leadership argues that robotaxis will reframe work rather than eliminate it, highlighting maintenance, fleet ...
IGIC's Q1 2026 results highlight growth momentum alongside margin pressure. This article breaks down the igic 2026 ea...
Oklo stock fell further as traders digested quarterly results and a new regulatory filing. This article breaks down w...
Nvidia's surge in AI chips is reshaping markets, and some analysts frame it as a $200 billion warning for rivals like...
As investors chase high yields, the location of the account matters. In a taxable setup, $60,000 of ordinary-income d...
Trump signals a deal with Iran could be signed this weekend, but Tehran cautions that no final agreement exists. Medi...